10,891
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Nutrition and Cancer: An Historical Perspective.—The Past, Present, and Future of Nutrition and Cancer. Part 2. Misunderstanding and Ignoring Nutrition

Pages 962-968 | Received 20 Mar 2017, Accepted 06 Apr 2017, Published online: 25 Jul 2017

References

  • Campbell TC: Nutrition and cancer: an historical perspective. 1. Was a nutritional association acknowledged a century ago? Nutr Cancer, 8(1): 1–7, 2017. doi: 10.1080/01635581.2017.1317823. [Epub ahead of print]
  • Committee on Diet Nutrition and Cancer: Diet, Nutrition and Cancer. National Academy Press, Washington, DC, 1982.
  • Garst JE: Council for Agricultural Science and Technology, Comments on Diet, Nutriton and Cancer. Ames, IO, 1982, pp. 28–29.
  • Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, et al.: Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New Engl J Med 334, 1150–1155, 1996.
  • Peto R, Doll R, and Buckley JD: Can dietary beta-carotene materially reduce human cancer rates? Nature 290, 201–208, 1981.
  • Hennekins CH, Burring JE, and Peto R: Antioxidant vitamins–benefits not yet proved. New Engl J Med 330, 1080–1081, 1994.
  • Macilwain G: John Abernethy, with a View of His Lectures, Writings, and Character. Hurst and Blackett Publishers, London, UK, 1854.
  • Select Committee on Nutrition and Human Needs (U.S. Senate): Dietary Goals for the United States, 2nd ed. Washington, DC: U.S. Government Printing Office, 1977, p. 83.
  • Brown JR and Thornton JL: Percivall Pott (1714–1788) and chimney sweepers' cancer of the scrotum. Br J Int Med 14, 68–70, 1957.
  • Woglam WH: Experimental tar cancer. Arch Pathol 2, 533–572, 709–752, 1926.
  • Weisburger JH: The 37 year history of the delaney clause. Exp Toxicol Pathol 48, 183–188, 1996.
  • National Toxicology Program: Report on Carcinogens. NC: Research Triangle Park, Research Triangle NC, 2011, p. 499.
  • Huff J, Jacobson MF, and Davis DL: The limits of two-year bioassay exposure regimens for identifying chemical carcinogens. Environ Health Perspect 116, 1439–1442, 2008.
  • International Agency for Cancer Research: Overall Evaluations of Carcinogenicity: An Upating of IARC Monographs Volumes 1 to 42, International Agency for Research On Cancer, Lyon, France, 1987, pp. 1–440.
  • Campbell TC: Chemical carcinogens and human risk assessment. Fed Proc 39, 2467–2484, 1980.
  • Campbell TC: A decision tree approach to the regulation of food chemicals associated with irreversible toxicities. Regul Tox Pharm 1, 193–201, 1981.
  • Siemiatycki J, Richardson L, Straif K, Latreille B, Lakhani R, et al.: Listing occupational carcinogens. Environ Health Perspect 112, 1447–1459, 2004.
  • Waldron HA: A brief history of scrotal cancer. Br J Ind Med 40, 390–401, 1983.
  • International Agency for Research on Cancer: Some Monomers, Plastics, and Synthetic Dyestuffs. International Agency for Research on Cancer, Lyon, France, 1979.
  • International Agency for Research on Cancer: Some Industrial Chemicals and Dyestuffs. International Agency for Research on Cancer, Lyon, France, 1982.
  • Expert Panel: Food, Nutrition and the Prevention of Cancer, a Global Perspective. Washington, DC: American Institute for Cancer Research/World Cancer Research Fund, 1997, p. 670.
  • World Cancer Research Fund/American Institute for Cancer Resarch: Food, Nutrition, Physical Activity, and Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research, 2007, p. 517.
  • United States Department of Health and Human Services: The Surgeon General's Report on Nutrition and Health. Superintendent of Documents, U.S. Government Printing Office, Washington, DC, 1988.
  • National Research Council & Committee on Diet and Health: Diet and Health: Implications for Reducing Chronic Disease Risk. National Academy Press, Washington, DC, 1989.
  • Campbell TC: Untold nutrition. Nutr Cancer 66, 1077–1082, 2014.
  • Wogan GN, Paglialunga S, and Newberne PM: Carcinogenic effects of low dietary levels of aflatoxin B1 in rats. Food Cosmet Toxicol 12, 681–685, 1974.
  • Wogan GN and Newberne PM: Dose-response characteristics of aflatoxin B1 carcinogenesis in the rat. Cancer Res 27, 2370–2376, 1967.
  • Campbell TC and Hayes JR: Role of nutrition in the drug metabolizing system. Pharmacol Revs 26, 171–197, 1974.
  • Adekunle AA, Hayes JR, and Campbell TC: Interrelationships of dietary protein level, aflatoxin B1 metabolism, and hepatic microsomal epoxide hydrase activity. Life Sci 21, 1785–1792, 1977.
  • Hayes JR, Mgbodile MUK, Merrill AH, Jr., Nerurkar LS, and Campbell TC: The effect of dietary protein depletion and repletion on rat hepatic mixed function oxidase activities. J Nutr 108, 1788–1797, 1978.
  • Hayes JR and Campbell TC: Effect of protein deficiency on the inducibility of the hepatic microsomal drug-metabolizing enzyme system. III. Effect of 3-methylcholanthrene induction on activity and binding kinetics. Biochem Pharmacol 23, 1721–1732, 1974.
  • Hayes JR, Mgbodile MUK, and Campbell TC: Effect of protein deficiency on the inducibility of the hepatic microsomal drug-metabolizing enzyme system. I. Effect on substrate interaction with cytochrome P-450. Biochem Pharmacol 22, 1005–1014, 1973.
  • Mgbodile MUK, Hayes JR, and Campbell TC: Effect of protein deficiency on the inducibility of the hepatic microsomal drug-metabolizing enzyme system. II. Effect on enzyme kinetics and electron transport system. Biochem Pharmacol 22, 1125–1132, 1973.
  • Mgbodile MUK and Campbell TC: Effect of protein deprivation of male weanling rats on the kinetics of hepatic microsomal enzyme activity. J Nutr 102, 53–60, 1972.
  • Preston RS, Hayes JR, and Campbell TC: The effect of protein deficiency on the in vivo binding of aflatoxin B1 to rat liver macromolecules. Life Sci 19, 1191–1198, 1976.
  • Booth SC, Bosenberg H, Garner RC, Herzog PJ, and Norpoth K: The activation of aflatoxin B1 in liver slices and in bacterial mutagenicity assays using livers from different species including man. Carcinogenesis 2, 1063–1068, 1981.
  • Garner RC, Miller EC, Miller JA, Garner JV, and Hanson RS: Formation of a factor lethal for S. Typhimurium TA1530 and TA1531 on incubation of aflatoxin B1 with rat liver microsomes. Biochem Biophys Res Commun 45, 774–780, 1971.
  • Dunaif GE and Campbell TC: Dietary protein level and aflatoxin B1-induced preneoplastic hepatic lesions in the rat. J Nutr 117, 1298–1302, 1987.
  • Dunaif GE and Campbell TC: Relative contribution of dietary protein level and aflatoxin B1 dose in generation of presumptive preneoplastic foci in rat liver. J Nat Cancer Inst 78, 365–369, 1987.
  • Youngman LD: The Growth and Development of Aflatoxin B1-Induced Preneoplastic Lesions, Tumors, Metastasis, and Spontaneous Tumors as They Are Influenced by Dietary Protein Level, Type, and Intervention. Ph.D. Thesis, Cornell University, Ithaca, NY, 1990.
  • Youngman LD and Campbell TC: High protein intake promotes the growth of preneoplastic foci in Fischer #344 rats: evidence that early reemodeled foci retain the potential for future growth. J Nutr 121, 1454–1461, 1991.
  • Youngman LD and Campbell TC: Inhibition of aflatoxin B1-induced gamma-glutamyl transpeptidase positive (GGT+) hepatic preneoplastic foci and tumors by low protein diets: evidence that altered GGT+ foci indicate neoplastic potential. Carcinogenesis 13, 1607–1613, 1992.
  • Hayes JR and Campbell TC: In: Modifiers of Chemical Carcinogenesis. Slaga TJ (ed.). Raven Press, Nutrition As Modifier of Chemical Carcinogenesis, New York, 1980, pp. 207–241.
  • Appleton BS and Campbell TC: Effect of high and low dietary protein on the dosing and postdosing periods of aflatoxin B1-induced hepatic preneoplastic lesion development in the rat. Cancer Res 43, 2150–2154, 1983.
  • Appleton BS and Campbell TC: Inhibition of aflatoxin-initiated preneoplastic liver lesions by low dietary protein. Nutr Cancer 3, 200–206, 1982.
  • Madhavan TV and Gopalan C: The effect of dietary protein on carcinogenesis of aflatoxin. Arch Path 85, 133–137, 1968.
  • Campbell TC, Chen J, Liu C, Li J, and Parpia B: Non-association of aflatoxin with primary liver cancer in a cross-sectional ecologic survey in the People's Republic of China. Cancer Res 50, 6882–6893, 1990.
  • Anonymous: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research On Cancer, Lyon, France, 2017.
  • Johnson IT: The cancer risk related to meat and meat products. Br Med Bull, 121, 73–81, 2016.
  • Euromonitor International: Dietary and Vitamin Supplements in the U.S. Country Report, Euromonitor International, London, 2016, p. 53.
  • Pitkala KH, Suominen MH, Bell JS, and Strandberg TE: Herbal medications and other dietary supplements. A clinical review for physicians caring for older people. Ann Med, 48, 586–602, 2016.
  • Rautiainen S, Manson JE, Lichtenstein AH, and Sesso HD: Dietary supplements and disease prevention—a global overview. Nat Rev Endocrinol 12, 407–420, 2016.
  • Newburgh LH and Clarkson S: The production of arteriosclerosis in rabbits by feeding diets rich in meat. Arch Intern Med 31, 653–676, 1923.
  • Newburgh LH and Clarkson S: The relation between atherosclerosis and ingested cholesterol in the rabbit. J Exp Med 43, 595–612, 1926.
  • Kritchevsky D, Tepper SA, Czarnecki SK, Klurfeld DM, and Story JA: In: Current Topics in Nutrition and Disease, Volume 8: Animal and Vegetable Proteins in Lipid Metabolism and Atherosclerosis. Kritchevsky D and Gibney MJ (eds.). Alan R. Liss, Inc., Effects of Animal and Vegetable Protein in Experimental Atherosclerosis, New York, 1983, pp. 85–100.
  • Sirtori CR, Noseda G, and Descovich GC: In: Current Topics in Nutrition and Disease, Volume 8: Animal and Vegetable Proteins in Lipid Metabolism and Atherosclerosis. Gibney MJ and Kritchevsky D (eds.). Alan R. Liss, Inc., Studies On the Use of a Soybean Protein Diet for the Management of Human Hyperlipoproteinemias, New York, 1983, pp. 135–148.